Concepedia
Statistics
Publications
2
Citations
129
H-Index
Active since
2014
Affiliations
Novartis (Switzerland)(Current)
Novartis (United States)
Novartis Institutes for BioMedical Research
Greg Hollingworth is an author at Novartis (Switzerland) specializing in drug discovery, proteasomal turnover, and pharmacology.
Publications per year
2014–2024
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
Martin Schröder, Martin Renatus, Xiaoyou Liang et al. · Nature Communications · 2024 · 88 citations · Full text
Life Sciences, Medicinal Chemistry, Molecular Biology +13
Novel ROCK inhibitors for the treatment of pulmonary arterial hypertension
Duncan Shaw, Greg Hollingworth, Nicolas Soldermann et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 41 citations · Full text
Medicine, Cardiology, Pharmacology +11
1–2 of 2